Conversation with Donal O’Shea Chief Executive at Deciphex
admin@pathologynews.com2024-02-19T09:37:09+00:00In this interview Donal O'Shea shares insights on the evolution of digital pathology, emphasizing strategic business positioning, market development, and the adoption of digital technologies in pathology. O’Shea highlights Deciphex's focus on improving drug safety assessment and clinical diagnostics through digital pathology and AI, aiming to address global pathologist shortages and enhance diagnostic efficiency.











